Rhino Novi is Consulting Services (B2B) in United States that focus on Biolife Sciences Inc business. They cover business area such as Biolife Sciences Inc, licensor, developer, innovative and disruptive technology, beauty, food, beverage, industry sector, Antimicrobial Copper Air Filters, Eco-Safe Surface Sanitizer, Eco-Safe Antimicrobial Treatment, Ultraviolet Sterilization, non, contact Human Temperature Screening, Next-Generation Vending Machines.
-
Biolife Sciences Inc
-
67 Wall Street
22nd Floor
New York, NY 10005
United States
Private
Biolife Sciences Inclicensordeveloperinnovative and disruptive technologybeautyfoodbeverageindustry sectorAntimicrobial Copper Air FiltersEco-Safe Surface SanitizerEco-Safe Antimicrobial TreatmentUltraviolet Sterilizationnoncontact Human Temperature ScreeningNext-Generation Vending Machines
* We use standard office opening hours in near Rhino Novi's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rhino Novi is Consulting Services (B2B) business from United States that founded in - ( years old in ), Rhino Novi business is focusing on Biolife Sciences Inc.
Rhino Novi headquarter office and corporate office address is located in 67 Wall Street 22nd Floor New York, NY 10005 United States.
Rhino Novi was founded in United States.
In , Rhino Novi is currently focus on Biolife Sciences Inc sector.
Above is snippet of Google Trends for "Biolife Sciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rhino Novi, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
